Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Delayed Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
2.67 USD +1.14% Intraday chart for SAB Biotherapeutics, Inc. -1.84% -61.16%
May. 30 SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer CI
May. 21 FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SAB BIOTHERAPEUTICS, INC.
Bio Therapeutic Drugs
+1.14%-1.84%-61.16%-70.87% - 24.63M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Charts SAB Biotherapeutics, Inc.
  5. Comparison Chart